selenocysteine has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doskas, TK; Ntoskas, KT; Vavougios, GD | 1 |
| Aloupis, M; Lyons, M; Sarani, B; Stawicki, SP | 1 |
1 review(s) available for selenocysteine and Critical Illness
| Article | Year |
|---|---|
Current evidence from phase III clinical trials of selenium supplementation in critically Ill patients: why should we bother?
Topics: Clinical Trials, Phase III as Topic; Critical Care; Critical Illness; Dietary Supplements; Glutathione Peroxidase; Humans; Selenium; Selenocysteine | 2007 |
1 other study(ies) available for selenocysteine and Critical Illness
| Article | Year |
|---|---|
Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients.
Topics: Blood Coagulation Disorders; Blood Platelets; COVID-19; Critical Illness; Endothelium, Vascular; Homeostasis; Humans; Immune System; Inflammation; Models, Theoretical; Oxidative Stress; Platelet Activation; SARS-CoV-2; Selenium; Selenocysteine; Transcriptome | 2021 |